Analysts Set GSK plc (LON:GSK) PT at GBX 1,842.50

Shares of GSK plc (LON:GSK - Get Free Report) have earned a consensus recommendation of "Moderate Buy" from the seven ratings firms that are currently covering the company, MarketBeat Ratings reports. One research analyst has rated the stock with a sell rating, one has assigned a hold rating and five have issued a buy rating on the company. The average 12-month price objective among brokers that have covered the stock in the last year is GBX 1,842.50 ($23.14).

A number of equities analysts have recently issued reports on GSK shares. Berenberg Bank reiterated a "buy" rating and issued a GBX 1,820 ($22.86) price target on shares of GSK in a report on Tuesday, September 10th. Deutsche Bank Aktiengesellschaft restated a "buy" rating and set a GBX 1,850 ($23.24) target price on shares of GSK in a report on Tuesday, September 3rd. JPMorgan Chase & Co. reaffirmed an "underweight" rating on shares of GSK in a report on Monday, July 29th. Finally, Shore Capital reissued a "buy" rating on shares of GSK in a research note on Wednesday, August 28th.

Insider Transactions at GSK

In other GSK news, insider Jonathan Symonds acquired 7,150 shares of the company's stock in a transaction dated Wednesday, October 30th. The stock was bought at an average price of GBX 1,394 ($17.51) per share, with a total value of £99,671 ($125,183.37). Also, insider Elizabeth (Liz) McKee Anderson bought 446 shares of GSK stock in a transaction that occurred on Monday, September 23rd. The shares were acquired at an average price of GBX 2,051 ($25.76) per share, for a total transaction of £9,147.46 ($11,488.90). Insiders have purchased a total of 7,604 shares of company stock worth $10,893,038 in the last three months. Company insiders own 1.61% of the company's stock.

GSK Stock Performance

Shares of GSK stock traded up GBX 4.50 ($0.06) on Monday, reaching GBX 1,346.50 ($16.91). 10,905,644 shares of the stock were exchanged, compared to its average volume of 10,172,983. The company has a current ratio of 0.82, a quick ratio of 0.73 and a debt-to-equity ratio of 123.04. The firm has a market capitalization of £54.94 billion, a PE ratio of 1,172.57, a PEG ratio of 1.24 and a beta of 0.31. GSK has a 1-year low of GBX 1,282.50 ($16.11) and a 1-year high of GBX 1,823.50 ($22.90). The business has a fifty day moving average price of GBX 1,460.77 and a two-hundred day moving average price of GBX 1,564.08.

GSK Dividend Announcement

The firm also recently disclosed a dividend, which will be paid on Thursday, January 9th. Stockholders of record on Thursday, November 14th will be issued a dividend of GBX 15 ($0.19) per share. This represents a dividend yield of 1.03%. The ex-dividend date is Thursday, November 14th. GSK's dividend payout ratio (DPR) is 5,309.73%.

GSK Company Profile

GSK plc, together with its subsidiaries, engages in the research, development, and manufacture of vaccines, and specialty and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally. It operates through two segments, Commercial Operations and Total R&D.